These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24581055)

  • 1. Term limits and the tobacco industry.
    Apollonio DE; Glantz SA; Bero LA
    Soc Sci Med; 2014 Mar; 104():1-5. PubMed ID: 24581055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are tobacco industry campaign contributions influencing state legislative behavior?
    Monardi F; Glantz SA
    Am J Public Health; 1998 Jun; 88(6):918-23. PubMed ID: 9618620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Money, politics, and medicine: the American Medical PAC's strategy of giving in U.S. house races.
    Wilkerson JD; Carrell D
    J Health Polit Policy Law; 1999 Apr; 24(2):335-55. PubMed ID: 10321360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public health under attack: the American Stop Smoking Intervention Study (ASSIST) and the tobacco industry.
    White J; Bero LA
    Am J Public Health; 2004 Feb; 94(2):240-50. PubMed ID: 14759933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
    Tong EK; England L; Glantz SA
    Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure to defend a successful state tobacco control program: policy lessons from Florida.
    Givel MS; Glantz SA
    Am J Public Health; 2000 May; 90(5):762-7. PubMed ID: 10800426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State legislators' attitudes and voting intentions toward tobacco control legislation.
    Goldstein AO; Cohen JE; Flynn BS; Gottlieb NH; Solomon LJ; Dana GS; Bauman KE; Munger MC
    Am J Public Health; 1997 Jul; 87(7):1197-200. PubMed ID: 9240112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Where there's smoke there's money: tobacco industry campaign contributions and U.S. Congressional voting.
    Luke DA; Krauss M
    Am J Prev Med; 2004 Dec; 27(5):363-72. PubMed ID: 15556735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobacco industry campaign contributions are affecting tobacco control policymaking in California.
    Glantz SA; Begay ME
    JAMA; 1994 Oct; 272(15):1176-82. PubMed ID: 7933347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying carcinogens: the tobacco industry and regulatory politics in the United States.
    Cook DM; Bero LA
    Int J Health Serv; 2006; 36(4):747-66. PubMed ID: 17175844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The creation of industry front groups: the tobacco industry and "get government off our back".
    Apollonio DE; Bero LA
    Am J Public Health; 2007 Mar; 97(3):419-27. PubMed ID: 17267719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus for tobacco policy among former state legislators using the policy Delphi method.
    Hahn EJ; Rayens MK
    Tob Control; 1999; 8(2):137-40. PubMed ID: 10478396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Working the system"--British American tobacco's influence on the European union treaty and its implications for policy: an analysis of internal tobacco industry documents.
    Smith KE; Fooks G; Collin J; Weishaar H; Mandal S; Gilmore AB
    PLoS Med; 2010 Jan; 7(1):e1000202. PubMed ID: 20084098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The devil is in the detail: tobacco industry political influence in the Dutch implementation of the 2001 EU Tobacco Products Directive.
    Lie JL; Willemsen MC; de Vries NK; Fooks G
    Tob Control; 2016 Sep; 25(5):545-50. PubMed ID: 26349910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Canadian legislators' support for tobacco control policies.
    Cohen JE; de Guia NA; Ashley MJ; Ferrence R; Northrup DA; Studlar DT
    Soc Sci Med; 2002 Sep; 55(6):1069-76. PubMed ID: 12220090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives. What is lost if Congress overrides the states' negotiated tobacco settlement?
    Cunningham R
    Med Health; 1998 Apr; 52(16):suppl 1-4. PubMed ID: 10179403
    [No Abstract]   [Full Text] [Related]  

  • 17. The tobacco wars: back to the states.
    Benjamin GC
    Physician Exec; 1998; 24(5):68-70. PubMed ID: 10185651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of Tobacco Harm Prevention Law in Vietnam: stakeholder tensions over tobacco control legislation in a state owned industry.
    Higashi H; Khuong TA; Ngo AD; Hill PS
    Subst Abuse Treat Prev Policy; 2011 Sep; 6():24. PubMed ID: 21923945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State legislators' perceptions of lobbyists and lobbying on tobacco control issues.
    Cohen JE; Goldstein AO; Flynn BS; Munger MC; Gottlieb NH; Solomon LJ; Dana GS
    Tob Control; 1997; 6(4):332-6. PubMed ID: 9583632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Fag Lady, revisited: Margaret Thatcher's efforts on behalf of the tobacco industry.
    Petticrew M; Krishnaratne S
    Public Health; 2014 Oct; 128(10):904-10. PubMed ID: 25239649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.